Active	Status	Sponsor type	Region	Phase	Filter
7 Active 12 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Anderson, Peter
NCT05140954: The Women TAF-FTC Benchmark Study	Completed	2/3	54	RoW	co-formulated 25mg TAF/ 200mg FTC, Descovy	University of Washington, Kenya Medical Research Institute, University of Colorado, Denver, Gilead Sciences	HIV Infections	12/23	12/23
NCT06435026: Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1	Recruiting	2	54	RoW	FTC/TDF 200mg/300mg, PrEP, FTC/TDF 300mg/450mg, FTC/TDF 400mg/600mg	University of North Carolina, Chapel Hill, National Institute of Allergy and Infectious Diseases (NIAID)	HIV, Prevention, Pregnancy	02/25	02/25
NCT05057858: The Women TDF-FTC Benchmark Study	Active, not recruiting	2	72	RoW	co-formulated 300 mg TDF/ 200mg FTC, Truvada	University of Washington, University of Colorado, Denver, Kenya Medical Research Institute, National Institute of Allergy and Infectious Diseases (NIAID)	HIV Infections	01/25	01/25
Tracer Pilot, NCT04535934: Novel Approaches for Quantitative Assessment of Adherence	Completed	N/A	15	US	Adenine 5+ (five stable-labeled nitrogens), taggant	University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID)	Healthy	11/22	11/22
ACT, NCT05335590: Adherence and Clinical Correlates in Persons With HIV on TAF	Active, not recruiting	N/A	384	US		University of Colorado, Denver	Hiv	05/25	05/25
NCT04065347: Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)	Completed	N/A	84	US	Digital Pill, etectRx ID-Cap System	University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID)	HIV/AIDS, Adherence, Medication	05/23	05/23
HOME-1, NCT04979728: HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots	Recruiting	N/A	150	US	At Home Self-Collections, Tasso-M20, Tasso+, Mitra, DBS by fingerstick	University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID)	HIV Treatment, HIV Prevention	12/25	12/25